Fish Oil for Period Cramps: What the Trials Say About Pain, Dose and Timing

A fish-oil bottle may list a large milligram number and promise menstrual comfort without explaining what you would be taking or how long improvement took in the research. Start with three questions: which fatty acids, which pain outcome and which comparison?

The larger review found a benefit, with substantial uncertainty

A review published in the 2024 issue of Nutrition & Dietetics included 12 studies involving 881 participants. Eight contributed to its meta-analysis, which favored omega-3 supplements for menstrual pain.¹

The pooled standardized effect was −1.02, with a 95% confidence interval of −1.53 to −0.51. This combines different measurement scales; it is not a one-point reduction on a particular pain scale. Results varied substantially (I² = 89%), and ten studies received a neutral quality rating, reflecting methodological limitations rather than a finding of no benefit.¹

Problems included short or absent washouts in crossover studies and incomplete descriptions of products and procedures. None measured prostaglandins in blood or menstrual fluid, so the proposed mechanism was not demonstrated in those trials.¹

The 2012 study allowed rescue ibuprofen

The Iranian study enrolled 100 students aged 18–22; 95 completed. Each received an omega-3 capsule containing 180 mg EPA and 120 mg DHA daily during one three-month period, and placebo during another. Treatment order followed odd or even registration numbers, making allocation predictable.²

Pain scores were lower during omega-3 treatment. Participants also used fewer rescue ibuprofen tablets. At the first three-month assessment, mean use was 4.3 tablets in the omega-3 group versus 6.0 with placebo; ibuprofen was permitted for severe pain. This supports a possible reduction in medicine use, not evidence that everyone could dispense with it.²

Only a one-week washout separated periods. The authors acknowledged this limitation. Effects carrying into the next period could complicate the crossover comparison. Semnan University of Medical Sciences funded the study.²

A 2025 trial did not settle the best combination

A newer Indian trial assigned 72 women aged 18–25, 18 per group, to observation, aerobic exercise, omega-3 capsules or both. It tested 12 weeks, with capsules described as 800 mg five days per week.³

At the end, mean pain scores were 5.47, 4.47, 4.11 and 4.06, respectively, on a 0–10 scale. The overall comparison across four groups was significant (P = 0.023). That test does not establish that the combination was significantly better than omega-3 alone, despite the authors’ stronger conclusion.³

The paper did not provide the individual EPA and DHA amounts. Its control group received neither placebo capsules nor an exercise programme, and some inflammatory markers differed at baseline. The study adds a positive signal, while leaving uncertainty about the contribution of each component and the product tested.³

Read EPA and DHA separately from the fish-oil total

The NIH Office of Dietary Supplements⁴ describes a typical 1,000 mg fish-oil supplement as containing 180 mg EPA plus 120 mg DHA, although products vary widely. That is 300 mg of those two fatty acids, not 1,000 mg.⁴

Look at the serving size too. A label may give amounts per two capsules rather than one. If you bring a product to a pharmacist or clinician, include the full label so the daily amounts and extra ingredients can be checked.

Flaxseed oil supplies ALA, another omega-3. The body converts only a limited amount into EPA and DHA. It should not be assumed to reproduce a trial of marine EPA and DHA merely because both labels say omega-3.⁴

These studies do not establish a universal dose. Their schedules also differ: daily use in the older crossover study and five days per week in the newer trial. Neither tested taking one capsule when a cramp began.²³

Agree on pain treatment and a review point

If you want to discuss adding fish oil, bring your existing medicines and supplement label. NIH guidance lists heartburn, nausea, unpleasant taste and other digestive symptoms among possible effects. It also advises reviewing interactions, including with warfarin and similar anticoagulants.⁴

Record pain and medicine use separately across cycles. Also note missed work, interrupted sleep or activities you could not do. A lower average pain score matters less if the most disabling day remains unchanged. Agree in advance what improvement would justify continuing a supplement and what to do for breakthrough pain.

Current UK NHS⁵ advice calls for urgent assessment when pelvic or period pain is severe or worse than usual and painkillers have not helped. Arrange a clinical review for increasingly painful, heavier or irregular periods, bleeding between periods, pain during sex or toileting, or pain that stops usual activities. Do not postpone that assessment to finish several supplement cycles.⁵

Chapter 7, “Cramps That Stop You,” in Period, Handled examines pain treatments and the supplement evidence. Use its emphasis on tracking pain and function to make the next review specific: what changed, over which cycles and alongside which treatment?